Ascentage Pharma Group International (AAPG) Finished Goods (2023 - 2025)

Ascentage Pharma Group International's Finished Goods history runs 3 years deep, the most recent figure standing at $1.0 million for Q4 2025.

• In Q4 2025, Finished Goods rose 94.81% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (up 94.81% YoY), while the FY2025 annual figure was $1.1 million, up 100.38% from the prior year.
• Finished Goods for Q4 2025 stood at $1.0 million, up from $537511.9 in the prior quarter.
• The five-year high for Finished Goods was $1.5 million in Q4 2023, with the low at $537511.9 in Q4 2024.
• The 3-year median for Finished Goods is $1.0 million (2025), against an average of $1.0 million.
• The sharpest annual moves came in 2024 and 2025: Finished Goods sank 65.06% in 2024, then jumped 94.81% in 2025.
• Ascentage Pharma Group International's Finished Goods stood at $1.5 million in 2023, then tumbled by 65.06% to $537511.9 in 2024, then soared by 94.81% to $1.0 million in 2025.
• Business Quant data shows AAPG's Finished Goods at $1.0 million in Q4 2025, $537511.9 in Q4 2024, and $1.5 million in Q4 2023.